Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients. Zhang J, Wang L, Zhang S, Cao R, et al. BMC Cancer 2024;24:266.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang J, Wang L, Zhang S, Cao R, et al. Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients. BMC Cancer 2024;24:266.
PMID: 38408930